Fluctuation imaging for liver hemangioma diagnosis
Part of Cancer clinical trials.
This study tests a new ultrasound technique called fluctuation imaging to see if it can accurately diagnose hepatic hemangiomas (a common type of non-cancerous liver tumor). If you have a liver spot detected on an ultrasound, this study may help confirm what it is without needing a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You have a liver spot (at least 1 cm) seen on an ultrasound.
- Either the spot's diagnosis is already known through a biopsy or another reliable scan, or it will be confirmed within one month of the study.
- You can hold your breath for at least 5 seconds during the ultrasound.
- The ultrasound image of your liver spot needs to be clear enough for the new technique to work.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, more detailed ultrasound technique to better see liver tumors. It may help doctors understand your tumor better without extra procedures.
This study compares two methods for reading contrast-enhanced ultrasound images to tell whether new liver spots after liver cancer treatment are cancer or not. If you have a new liver lesion after prior treatment, this scan may help doctors decide your next steps more accurately.
This study tests a new ultrasound technique to catch liver cancer sooner. If you have regular imaging checks for liver cancer or are getting an MRI for a liver spot, you may be able to join.
This study tests if non-invasive imaging (like ultrasound) can replace liver biopsies in children with liver disease. It may help avoid the need for a needle biopsy in the future.
This trial uses a special ultrasound with contrast dye to get a clearer picture of liver spots that other scans (CT, MRI, or PET) couldn't fully identify. The goal is to see if this ultrasound can help doctors make a more accurate diagnosis.
This study compares a shorter, non-contrast MRI and ultrasound to monitor for liver cancer in people with cirrhosis whose ultrasound images aren’t clear enough. It aims to see which method works better and may help you get safer, more reliable follow-up.
Hear when a new Hemangioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.